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Introduction
Diagnostic microbiology and the traditional biochemical and 
the phenotype based morphological techniques that accompany 
it, have been a staple of pathological testing for the last 80 years [1]. 
Current methods for elucidating the agent responsible for causing an 
infection in humans rely on the observation of bacterial cells as well as 
biochemical testing aimed at utilising the metabolism of the organism 
as an indicator of its identity [2]. Following these observations, an 
experienced pathologist will then report on the likely identity of 
the pathogen leading to the treatment of a patient with appropriate 
antibiotics. Systems such as the API 20E (Biomerieux) have made 
performing these tests a much more streamlined and standardised 
procedure, however the bacterial identities are not always correct or 
specific enough to be of diagnostic use, only offering genus or species 
level identifications [3]. Biochemical based tests are also often expensive 
and require incubation periods that lengthen the time required for 
diagnosis thereby increasing the morbidity of patients with serious 
infections [4]. When all the above is considered, there was a drastic 
need for improvement in microbiological diagnoses which arrived in 
the form of Biotyping, first pioneered by Daltonics [5].
Biotyping is an analysis technique that uses Matrix Assisted Laser 
Desorption Ionisation Mass Spectrometry (MALDI-MS) to identify 
microorganisms by analysing the molecules that are in the highest 
abundance, such as ribosomal proteins and cold-shock proteins, and 
are the most easily ionisable from a range of clinical samples. In short, 
a small amount of bacterial cells are grown on appropriate agar media 
(or directly sampled by colony picking) and 1-2 colonies are collected 
and prepared according to a proprietary protocol to extract molecules 
that can be analysed by the mass spectrometer [6]. The instrument then 
analyses the sample and compares the data back to a reference database 
that contains a spectral library of known organisms. Any matching 
entries are then reported with a simplified scoring system that indicates 
the confidence in the identification; red for not confident, yellow for 
partially confident and green for very confident [5]. Clinicians are then 
provided with the report and the appropriate action is taken to treat the 
patient; The total process from human sample to identification takes 
~ 25 h depending on the length of time needed to grow the sample 
on agar media with sample preparation taking only 20 min. There are 
numerous advantages to such a system including faster responses and 
therefore faster treatment for patients, reduced costs, automation of 
sample analysis and a simple protocol that can be performed by “walk 
up” users. From a cost perspective individual samples have been 
determined as costing € 1.43 per sample as opposed to ~ €10-13 for 
systems such as the API 20E biochemical test strip. When combined 
with gram staining and other routine phenotypic tests costs can easily 
be ~ €25 per sample [7]. However, despite these benefits, Biotyping 
is still in need of significant improvement before it can truly replace 
traditional methodologies.
 In recent years we have begun our own investigation into the 
application of MALDI for bacterial diagnosis and, by applying our 
extensive knowledge in MALDI-TOF based technology [8,9], have 
discerned a number of key limitations with currently implemented 
Biotyping methodologies. The greatest limitation is that several major 
pathogen groups, responsible for a large proportion of clinical infections, 
such as Staphylococcus spp., Streptococcus spp. and Escherischia coli/
Shigella subgenus, are indistinguishable beyond the genus level [10] 
meaning they cannot be accurately identified without further testing. 
In addition to this, there is a high rate of misidentification [11] with a 
range ~ 85%-97% of organisms able to be accurately identified to genus 
or species level, depending on the organism. It should be noted that the 
identification to strain level has not yet been reliably achieved and is 
still in its developmental infancy [12].   
Another major issue is that current methodologies do not ensure 
the death of the pathogen before loading into the instrument for 
analysis. We have personally repeated the available methodologies 
and have confirmed this to be true; we will be publishing our findings 
shortly (manuscript in preparation). This poses a risk of infection by 
potentially high risk group human pathogens to pathology staff as well 
as engineers who are responsible for servicing the instrument.
As stated above, the rate of misidentification and the level to 
which organisms are identified are in need of significant improvement. 
However in the opinion of these authors, certain additional directions 
need to be explored to fully realise the potential of this technology.
Currently no single microbiological diagnostic in existence is able 
to accurately discern the identity of a pathogen from a clinical sample 
to strain or sub-strain accuracy, meaning that degrees of pathogenicity, 
that can often only be determined at strain level, are not able to be 
discerned. A good example of this is genus/species E. coli which contains 
a range of pathogenic and non-pathogenic strains. These including 
BL21 cells, used for recombinant protein production workflows [13] 
and O104:H4 Enteroaggregative -haemorrhagic strains that cause 
severe disease [14], but current Biotyping methodologies are unable to 
distinguish between a benign and pathogenic strain. If Biotyping were 
improved in the ways mentioned above and implemented in hospitals 
and pathology laboratories, the quality of patient care will dramatically 
increase and the current cost of healthcare will decrease as the detection 
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and identification of pathogens will become faster and more accurate 
leading to faster more targeted treatments.
It is extensively documented in the literature that antibiotic 
resistance is rapidly spreading and that bacteria are able to rapidly 
transfer this resistance to sensitive cells through mechanisms 
such as lateral gene transfer [14]. There is currently no rapid assay 
available to show the presence or specificity of antibiotic resistance 
in microorganisms. Antibiotic resistance and the resulting emergent 
diseases have a significant impact on global health systems with certain 
virulent pathogens such as extreme resistance Pseudomonas aeruginosa 
requiring targeted treatment with potentially toxic 4th line antibiotics 
[15]. If a rapid diagnostic could be applied to determine the  antibiotic 
resistance of the bacteria infecting a patient without determination of 
the bacteria’s identity, then treatments could become more targeted 
leading to increased patient outcomes and a reduction in emerging 
pathogens resulting from treatments with broad spectrum antibiotics 
[16].
MALDI Biotyping is a technique that is currently showing 
great potential in the field of microbial identification. With further 
exploration and expansion of this technique it could well prove to be 
the next ubiquitous diagnostic platform for human clinical samples. 
However, current implementations of this technology are in need 
of significant improvement in the areas of antibiotic resistance, 
identification accuracy and taxonomic level of identification. Once 
these areas have been addressed, microbial diagnostics will finally see 
a true renaissance.
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